News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,303 Results
Type
Article (41986)
Company Profile (273)
Press Release (690028)
Multimedia
Podcasts (95)
Webinars (20)
Section
Business (205179)
Career Advice (2044)
Deals (35622)
Drug Delivery (128)
Drug Development (81659)
Employer Resources (173)
FDA (16537)
Job Trends (15042)
News (347357)
Policy (32784)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2623)
Accelerated approval (48)
Adcomms (27)
Allergies (171)
Alliances (49679)
ALS (212)
Alzheimer's disease (1816)
Antibody-drug conjugate (ADC) (445)
Approvals (16909)
Artificial intelligence (660)
Autoimmune disease (290)
Automation (56)
Bankruptcy (362)
Best Places to Work (11684)
BIOSECURE Act (20)
Biosimilars (220)
Biotechnology (181)
Bladder cancer (188)
Brain cancer (71)
Breast cancer (747)
Cancer (5793)
Cardiovascular disease (467)
Career advice (1734)
Career pathing (42)
CAR-T (332)
CDC (57)
Celiac Disease (3)
Cell therapy (900)
Cervical cancer (47)
Clinical research (70887)
Collaboration (2052)
Company closure (5)
Compensation (1389)
Complete response letters (80)
COVID-19 (2743)
CRISPR (107)
C-suite (1120)
Cystic fibrosis (152)
Data (7860)
Decentralized trials (3)
Denatured (28)
Depression (169)
Dermatology (86)
Diabetes (586)
Diagnostics (6928)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (317)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92145)
Editorial (67)
Employer branding (21)
Employer resources (152)
Events (119731)
Executive appointments (1081)
FDA (20247)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (34)
Funding (1726)
Gene editing (233)
Generative AI (56)
Gene therapy (721)
GLP-1 (1057)
Government (4737)
Grass and pollen (6)
Guidances (408)
Healthcare (19024)
HIV (80)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (289)
Immuno-oncology (92)
Indications (191)
Infectious disease (3080)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (289)
Interviews (322)
IPO (16680)
IRA (50)
Job creations (3663)
Job search strategy (1438)
JPM (61)
Kidney cancer (19)
Labor market (100)
Layoffs (564)
Leadership (41)
Legal (7963)
Liver cancer (99)
Longevity (32)
Lung cancer (761)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1044)
MASH (186)
Medical device (13948)
Medtech (14069)
Mergers & acquisitions (20185)
Metabolic disorders (1498)
mRNA (205)
Multiple sclerosis (187)
NASH (17)
Neurodegenerative disease (426)
Neuropsychiatric disorders (110)
Neuroscience (3361)
Neurotech (1)
NextGen: Class of 2026 (6546)
Non-profit (4541)
Now hiring (78)
Obesity (702)
Opinion (287)
Ovarian cancer (219)
Pain (254)
Pancreatic cancer (299)
Parkinson's disease (368)
Partnered (33)
Patents (593)
Patient recruitment (668)
Peanut (62)
People (59697)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22096)
Phase 2 (31233)
Phase 3 (23232)
Pipeline (8699)
Policy (317)
Postmarket research (2572)
Preclinical (9436)
Press Release (64)
Prostate cancer (299)
Psychedelics (54)
Radiopharmaceuticals (320)
Rare diseases (1074)
Real estate (5986)
Recruiting (70)
Regulatory (25403)
Reports (56)
Research institute (2433)
Resumes & cover letters (354)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (180)
Series A (291)
Series B (216)
Service/supplier (11)
Sickle cell disease (112)
Special edition (27)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3655)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (87)
The Weekly (65)
Vaccines (1089)
Venture capital (109)
Weight loss (451)
Women's health (125)
Worklife (20)
Date
Today (53)
Last 7 days (856)
Last 30 days (3493)
Last 365 days (30126)
2026 (12432)
2025 (30257)
2024 (35295)
2023 (40157)
2022 (51251)
2021 (55790)
2020 (54152)
2019 (46601)
2018 (35085)
2017 (32171)
2016 (31585)
2015 (37657)
2014 (31432)
2013 (26463)
2012 (28658)
2011 (29324)
2010 (27378)
Location
Africa (742)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39781)
Australia (6536)
California (13259)
Canada (3766)
China (1342)
Colorado (566)
Connecticut (577)
Delaware (403)
Europe (86226)
Florida (1984)
Georgia (425)
Hawaii (3)
Idaho (62)
Illinois (1065)
India (90)
Indiana (600)
Iowa (23)
Japan (534)
Kansas (131)
Kentucky (50)
Louisiana (40)
Maine (76)
Maryland (1587)
Massachusetts (9469)
Michigan (362)
Minnesota (718)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (142)
New Hampshire (84)
New Jersey (3484)
New Mexico (29)
New York (3474)
North Carolina (1680)
North Dakota (9)
Northern California (6647)
Ohio (396)
Oklahoma (23)
Oregon (41)
Pennsylvania (2668)
Puerto Rico (29)
Rhode Island (50)
South America (1115)
South Carolina (85)
South Dakota (2)
Southern California (5224)
Tennessee (211)
Texas (2106)
United States (46792)
Utah (394)
Vermont (1)
Virginia (321)
Washington D.C. (81)
Washington State (1062)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
732,303 Results for "minerva neurosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates
May 5, 2026
·
16 min read
Press Releases
Minerva Neurosciences to Participate in The Citizens Life Sciences Conference
March 4, 2026
·
1 min read
Press Releases
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum
March 12, 2026
·
1 min read
Press Releases
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
March 11, 2026
·
19 min read
Press Releases
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
April 1, 2026
·
7 min read
Press Releases
Minerva Neurosciences Presents Data from its Open-label Safety Trial Evaluating Roluperidone Co-administered with Olanzapine at SIRS 2026
March 26, 2026
·
2 min read
Press Releases
Minerva Announces Leadership Transition
April 3, 2026
·
5 min read
Press Releases
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
November 20, 2025
·
7 min read
Press Releases
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
November 6, 2025
·
8 min read
Press Releases
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
January 27, 2026
·
7 min read
1 of 73,231
Next
